Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.92 BRL | +1.73% | -2.33% | -8.82% |
May. 08 | Transcript : Wilson Sons S.A., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Sales 2024 * | 469M 2.41B | Sales 2025 * | 544M 2.8B | Capitalization | 1.36B 6.98B |
---|---|---|---|---|---|
Net income 2024 * | 69M 354M | Net income 2025 * | 77M 395M | EV / Sales 2024 * | 3.94 x |
Net Debt 2024 * | 484M 2.49B | Net Debt 2025 * | 464M 2.38B | EV / Sales 2025 * | 3.35 x |
P/E ratio 2024 * |
19.7
x | P/E ratio 2025 * |
17.5
x | Employees | 3,800 |
Yield 2024 * |
2.56% | Yield 2025 * |
2.88% | Free-Float | 43.48% |
Latest transcript on Wilson Sons S.A.
1 day | +1.73% | ||
1 week | -2.33% | ||
Current month | -5.24% | ||
1 month | -5.24% | ||
3 months | -6.24% | ||
6 months | +2.45% | ||
Current year | -8.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 15-12-31 | |
Chairman | 64 | 93-12-31 | |
Chief Operating Officer | 67 | 79-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Salomon
BRD | Director/Board Member | 66 | - |
Chairman | 64 | 93-12-31 | |
Director/Board Member | 74 | 90-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 15.92 | +1.73% | 389,200 |
24-05-22 | 15.65 | -1.63% | 983,700 |
24-05-21 | 15.91 | +0.06% | 477,600 |
24-05-20 | 15.9 | -1.18% | 1,038,100 |
24-05-17 | 16.09 | -1.29% | 577,200 |
Delayed Quote Sao Paulo, May 23, 2024 at 04:06 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.82% | 1.34B | |
+42.30% | 12.26B | |
+17.73% | 6.23B | |
+5.59% | 2.46B | |
-10.00% | 2.09B | |
+8.27% | 1.78B | |
+33.85% | 1.2B | |
+21.28% | 1.04B | |
-.--% | 993M | |
+5.17% | 660M |
- Stock Market
- Equities
- PORT3 Stock